Biosafety and biosecurity: treading China's synbio tightrope.
Trends Biotechnol
; 42(4): 389-392, 2024 Apr.
Article
en En
| MEDLINE
| ID: mdl-37957090
ABSTRACT
Our second piece dissects China's intricate balancing act in synthetic biology (synbio), analyzing its adept maneuvering between fostering innovation and imposing strict regulations. The priority is enhancing biosecurity, biosafety, and public trust, crucial for sustainable gene editing advancements and preventing potential misuse of synthetic viruses.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Contención de Riesgos Biológicos
/
Bioaseguramiento
País como asunto:
Asia
Idioma:
En
Año:
2024
Tipo del documento:
Article